Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antibiotics >  Other antibiotic Drugs >  4-HYDROXYTAMOXIFEN

4-HYDROXYTAMOXIFEN

Basic information Safety Supplier Related

4-HYDROXYTAMOXIFEN Basic information

Product Name:
4-HYDROXYTAMOXIFEN
Synonyms:
  • trans-4-Hydroxytamoxifen, (Z)-4-(1-[4-(Dimethylaminoethoxy)phenyl]-2-phenyl-1-butenyl)phenol
  • (Z)-3,4-Diphenyl-4-[4-[2-(dimethylamino)ethoxy]phenyl]-3-buten-1-ol
  • 2-[4-[(E)-1-(4-Hydroxyphenyl)-2-phenyl-1-butenyl]phenoxy]-N,N-dimethylethanamine
  • 4-[(E)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol
  • cis-4-Hydroxytamoxifen
  • N,N-Dimethyl-2-[4-[(E)-1-(4-hydroxyphenyl)-2-phenyl-1-butenyl]phenoxy]ethanamine
  • trans-4-Hydroxytamoxifen
  • TAMOXIFEN 4-HYDROXY, (E) AND (Z) ISOMERS (50:50)
CAS:
68047-06-3
MF:
C26H29NO2
MW:
387.51
Product Categories:
  • Aromatics
  • Metabolites & Impurities
  • Drug Analogues
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Steroids
Mol File:
68047-06-3.mol
More
Less

4-HYDROXYTAMOXIFEN Chemical Properties

Melting point:
105-107°C
Boiling point:
513.45°C (rough estimate)
Density 
1.1005 (rough estimate)
refractive index 
1.6000 (estimate)
storage temp. 
2-8°C
solubility 
95% ethanol: 20 mg/mL
form 
powder
pka
10.35±0.15(Predicted)
color 
white
Stability:
Stable. Store cool. Incompatible with strong oxidizing agents.
InChIKey
TXUZVZSFRXZGTL-OCEACIFDSA-N
CAS DataBase Reference
68047-06-3
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
20/21/22-63
Safety Statements 
22-23-36
WGK Germany 
3
RTECS 
SL1210000
More
Less

4-HYDROXYTAMOXIFEN Usage And Synthesis

Chemical Properties

Powder

Uses

A metabolite of Tamoxifen (T006000). A hydroxylated analogue of Tamoxifen with anti-estrogenic properties.

Uses

(Z)-4-Hydroxy Tamoxifen is a metabolite of Tamoxifen (T006000). (Z)-4-Hydroxy Tamoxifen is a hydroxylated analogue of Tamoxifen. (Z)-4-Hydroxy Tamoxifen is a metabolite of Tamoxifen with anti-estrogenic properties.

Uses

tamoxifen metabolite, anti-estrogen, see Tamoxifen 1,01038

Uses

A hydroxylated analogue of tamoxifen with anti-estrogenic properties. A metabolite of Tamoxifen.

Definition

ChEBI: Afimoxifene is a tertiary amino compound that is tamoxifen in which the phenyl group which is in a Z- relationship to the ethyl substituent is hydroxylated at the para- position. It is the active metabolite of tamoxifen. It has a role as an antineoplastic agent, an estrogen receptor antagonist and a metabolite. It is a tertiary amino compound and a member of phenols. It is functionally related to a tamoxifen.

General Description

A cell-permeable, active metabolite of Tamoxifen (Cat. No. 579000) that acts as a potent inhibitor of PKC. It is more potent than the parent compound and inhibits PKC by modifying its catalytic domain. Also available as a 10 mM solution in EtOH (Cat. No. 508225).

Biological Activity

estrogen receptors (er) are members of the superfamily of ligand-modulated nuclear receptors that mediate the actions of steroid hormones, vitamin d, retinoids, and thyroid hormones. er is activated in vivo when bound by naturally occurring estrogens such as 17α-estradiol. in addition to regulating these physiological processes, estrogen also plays a central role in stimulating breast cancer growth. (z)-tamoxifen is a first generation selective er modulators that is currently approved by the fda and is widely used to treat estrogen-dependent breast cancers. its active metabolite, (z)-4-hydroxytamoxifen, is a potent estrogen receptor modulator.

Biochem/physiol Actions

Cell permeable: yes

in vitro

(z)-4-hydroxytamoxifen binds to er with 8-fold higher affinity than tamoxifen. it was found that only the z isomer has the required antiestrogenic activity; the (e)-4-hydroxytamoxifen has only about 5% of its affinity for the er [1].

in vivo

the antioestrogenic activities of (z)-4-hydroxytamoxifen and tamoxifen were determined after oral administration. (z)-4-hydroxytamoxifen was administered to groups of immature rats which also received s.c. injections of 0-2 μg oestradiol. both compounds produced a dose-related decrease in uterine wet weight when compared with the oestradiol-treated controls. at a dose of 1 μg/day, the antiuterotrophic effects of (z)-4-hydroxytamoxifen and tamoxifen were not significantly different but at 5μg/day, (z)-4-hydroxytamoxifen was more active (p < 0.01). (z)-4-hydroxytamoxifen therefore appears to retain its potent antioestrogenic activity after oral administration [2].

storage

-20°C

References

[1] donna d. yu and barry m. forman. simple and efficient production of (z)-4-hydroxytamoxifen, a potent estrogen receptor modulator. j. org. chem. 2003, 68, 9489-9491
[2] jordan vc, collins mm, rowsby l, prestwich g. a monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity. j endocrinol. 1977 nov;75(2):305-16.

4-HYDROXYTAMOXIFENSupplier

EVERGREEN BIO-PHARM CO., LTD Gold
Tel
13522905323
Email
sales@hxybio.com
Beijing Jiuqi chemicals co.,LTD Gold
Tel
17622371216
Email
799652097@qq.com
Hubei Jusheng Technology Co.,Ltd Gold
Tel
027-59599241 18871490274
Email
1400878000@qq.com
Chemleader Biomedical Co., Limited. Gold
Tel
021-58180488
Email
sales@Medchemleader.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com